Table 2 HBsAg and hepatitis C serology results by age and gender over the 14-year study period
From: Viral hepatitis in correctional facilities in the Northern Territory of Australia 2003–2017
HBsAg (Positive Results/Number of Tests) | Hepatitis C (Positive Results/Number of Tests) | |
|---|---|---|
Age < 21 | 43/1896 (2.3, 95% CI 1.6–3.0) | 15/1929 (0.8, 95% CI 0.4–1.3) |
Age 21–25 | 83/2153 (3.9, 95% CI 3.1–4.8) | 58/2242 (2.6, 95% CI 2.0–3.3) |
Age 26–30 | 106/2114 (5.0, 95% CI 4.1–6.0) | 113/2170 (5.2, 95% CI 4.3–6.2) |
Age 31–35 | 114/1813 (6.3, 95% CI 5.2–7.5) | 105/1855 (5.7, 95% CI 4.7–6.8) |
Age 36–40 | 120/1563 (7.7, 95% CI 6.4–9.1) | 94/1577 (6.0, 95% CI 4.8–7.2) |
Age 41–45 | 73/1136 (6.4, 95% CI 5.1–8.0) | 90/1083 (8.3, 95% CI 6.7–10.1) |
Age 46–50 | 53/711 (7.5, 95% CI 5.6–9.6) | 58/685 (8.5, 95% CI 6.5–10.8) |
Age 51–55 | 30/367 (8.2, 95% CI 5.6–11.5) | 23/358 (6.4, 95% CI 4.1–9.5) |
Age 56–60 | 14/206 (6.8, 95% CI 3.8–11.1) | 9/155 (5.5, 95% CI 2.5–10.1) |
Age > 61 | 5/107 (4.7, 95% CI 1.5–10.6) | 4/89 (4.5, 95% CI 1.2–11.1) |
Male | 601/10,586 (5.7, 95% CI 5.2–6.1) | 499/10,725 (4.7, 95% CI 4.2–5.1) |
Female | 40/1480 (2.7, 95% CI 1.9–3.7) | 70/1428 (4.9, 95% CI 3.8–6.2) |